These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36033805)

  • 1. The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance: Moderating roles of scientific collaboration strength and patent stock.
    Wang XX; Jiao HY
    Front Public Health; 2022; 10():980845. PubMed ID: 36033805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partners' centrality in scientific collaboration and exploratory innovation: Roles of patent stock and structural holes.
    Wang X; Zhong X; Jiao H
    Heliyon; 2024 Jul; 10(13):e33958. PubMed ID: 39071616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divisive Faultlines and Knowledge Search in Technological Innovation Network: An Empirical Study of Global Biopharmaceutical Firms.
    Cheng L; Wang M; Lou X; Chen Z; Yang Y
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34074011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management or technology? Firms' embeddedness in dual talent flow networks and their innovation performance.
    Sun B; Ruan A; Peng B; Liu S
    Front Psychol; 2022; 13():1028818. PubMed ID: 36425841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of digital industry agglomeration on firms' carbon emissions: new micro-evidence from Chinese manufacturing firms.
    Yang Y; Zhu Y; Zhang Y
    Environ Sci Pollut Res Int; 2024 Jul; 31(35):48332-48350. PubMed ID: 39028460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The moderating effect of psychological trust on knowledge spillovers and firms' open innovation.
    Huang R; Jin J; Sunguo T; Liu Y
    Front Psychol; 2022; 13():1071625. PubMed ID: 36582341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Cooperative Innovation on the Technological Innovation Performance of High-Tech Firms: A Dual Moderating Effect Model of Big Data Capabilities and Policy Support.
    Li X; Wang Q; Shi R; Wang X; Zhang K; Liu X
    Big Data; 2024 Feb; 12(1):63-80. PubMed ID: 37707986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collaboration with universities and innovate activity in the Spanish pharmaceutical industry (2003-2005)].
    D'Este P; Tribó JA; García-Romero A
    Med Clin (Barc); 2008 Dec; 131 Suppl 5():66-70. PubMed ID: 19631826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the influence of global innovation networks on corporate innovation: evidence from the international semiconductor industry.
    Wu Y; Ding L; Li N; Yu X
    Sci Rep; 2024 May; 14(1):11007. PubMed ID: 38745006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
    Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
    PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of environmental regulatory instruments on agribusiness technology innovation-A study of configuration effects based on fsQCA.
    Xia J; Zhang L; Song Y
    PLoS One; 2024; 19(1):e0294662. PubMed ID: 38236829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Do Heterogeneous Networks Affect a Firm's Innovation Performance? A Research Analysis Based on Clustering and Classification.
    Zhang L; Qiu H; Chen J; Zhou W; Li H
    Entropy (Basel); 2023 Nov; 25(11):. PubMed ID: 37998252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supply network position, digital transformation and innovation performance: Evidence from listed Chinese manufacturing firms.
    Du C; Zhang Q
    PLoS One; 2022; 17(12):e0279133. PubMed ID: 36520812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreign executives, digital transformation, and innovation performance: Evidence from Chinese-listed firms.
    Shao D; Lv K; Fan X; Zhang B
    PLoS One; 2024; 19(6):e0305144. PubMed ID: 38848381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning inward in difficulties: R&D human resource slack, technological diversification, and independent innovation.
    Li H; Zhao Y; Li Y; Wang Y
    PLoS One; 2024; 19(6):e0298453. PubMed ID: 38870238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of patent infringement litigation decisions on firms' innovation performance in China.
    Deng Y; Qi Y; Guo Q
    Sci Rep; 2024 Oct; 14(1):23564. PubMed ID: 39384940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. China's Carbon Emissions and Trading Pilot, Political Connection, and Innovation Input of Publicly Listed Private Firms.
    Liu W; Yu C; Cheng S; Xu J; Wu Y
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous knowledge spillover channels in universities and green technology innovation in local firms: Stimulating quantity or quality?
    Nie L; Gong H; Zhao D; Lai X; Chang M
    Front Psychol; 2022; 13():943655. PubMed ID: 36300040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will the Volume-Based Procurement Policy Promote Pharmaceutical Firms' R&D Investment in China? An Event Study Approach.
    Hu Y; Chen S; Qiu F; Chen P; Chen S
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does environmental innovation have peer effects? The moderating role of slack resources and avoidance goal orientation.
    Liao Z; Zheng P; Bao P
    Environ Res; 2024 Jul; 252(Pt 3):119019. PubMed ID: 38688416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.